Clinical Trial Update: Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for jaktinib hydrochloride tablets in active ankylosing spondylitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Jaktinib hydrochloride tablets (Jaktinib hydrochloride)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED